Nature's Sunshine Products (NASDAQ:NATR) Stock Rating Lowered by Wall Street Zen

Key Points

• Wall Street Zen downgraded Nature’s Sunshine Products from “strong buy” to “buy,” while the stock maintains an overall “buy” consensus and an average analyst price target of $34.50.
• NATR’s latest quarterly results missed expectations, with EPS of $0.21 versus $0.27 forecast and revenue of $116.99 million versus $123.70 million expected. The company also lowered its 2026 revenue outlook to $490 million–$500 million.
• The stock opened at $16.38, down 19.5%, amid performance concerns; insiders sold 35,696 shares worth $742,407 during the last quarter, while institutional investors own 79.4% of the company.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a research report issued to clients and investors on Saturday.

Other research analysts also recently issued research reports about the company. Weiss Ratings downgraded Nature's Sunshine Products from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Tuesday, June 9th. DA Davidson raised Nature's Sunshine Products to a "strong-buy" rating in a research note on Monday, July 6th. Finally, Canaccord Genuity Group reduced their price target on Nature's Sunshine Products from $37.00 to $36.00 and set a "buy" rating for the company in a report on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $34.50.

Nature's Sunshine Products Stock Down 19.5%

NATR stock opened at $16.38 on Friday. The company has a 50 day moving average of $20.62 and a two-hundred day moving average of $23.50. The company has a market cap of $287.96 million, a price-to-earnings ratio of 16.22 and a beta of 0.88. Nature's Sunshine Products has a 12-month low of $12.97 and a 12-month high of $28.14.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.27 by ($0.06). Nature's Sunshine Products had a net margin of 3.68% and a return on equity of 12.97%. The company had revenue of $116.99 million for the quarter, compared to analysts' expectations of $123.70 million.

Insider Buying and Selling at Nature's Sunshine Products

In other Nature's Sunshine Products news, EVP Bryant J. Yates sold 11,968 shares of the stock in a transaction on Friday, June 5th. The shares were sold at an average price of $19.90, for a total transaction of $238,163.20. Following the transaction, the executive vice president directly owned 77,446 shares of the company's stock, valued at $1,541,175.40. This represents a 13.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Daniel C. Norman sold 9,713 shares of the stock in a transaction on Monday, June 1st. The stock was sold at an average price of $20.64, for a total transaction of $200,476.32. Following the transaction, the executive vice president directly owned 47,276 shares in the company, valued at $975,776.64. The trade was a 17.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 35,696 shares of company stock worth $742,407 over the last quarter. Company insiders own 3.10% of the company's stock.

Institutional Trading of Nature's Sunshine Products

Large investors have recently made changes to their positions in the stock. State of Alaska Department of Revenue bought a new position in shares of Nature's Sunshine Products in the 4th quarter valued at approximately $31,000. New York State Teachers Retirement System bought a new stake in Nature's Sunshine Products during the first quarter worth approximately $37,000. Raymond James Financial Inc. bought a new stake in Nature's Sunshine Products during the second quarter worth approximately $37,000. Clearstead Advisors LLC grew its holdings in Nature's Sunshine Products by 16,025.0% during the fourth quarter. Clearstead Advisors LLC now owns 1,935 shares of the company's stock valued at $42,000 after purchasing an additional 1,923 shares during the last quarter. Finally, McIlrath & Eck LLC acquired a new position in Nature's Sunshine Products during the first quarter valued at approximately $48,000. Institutional investors own 79.40% of the company's stock.

Trending Headlines about Nature's Sunshine Products

Here are the key news stories impacting Nature's Sunshine Products this week:

• Neutral Sentiment: Nature’s Sunshine appointed Ruth Perkins as executive vice president and chief financial officer, effective September 1, 2026. She will oversee the company’s global finance organization, including financial planning, accounting, treasury, tax, investor relations, and financial reporting. Nature's Sunshine Appoints Ruth Perkins as Executive Vice President and Chief Financial Officer
• Neutral Sentiment: Management discussed the second-quarter performance and business outlook during its earnings call, providing additional context for the results and updated guidance. Nature's Sunshine Products Q2 2026 Earnings Call Transcript
• Negative Sentiment: Second-quarter adjusted earnings were $0.21 per share, below the $0.27 analyst consensus, while revenue of $116.99 million trailed expectations of $123.70 million. The earnings and sales shortfalls raised concerns about near-term profitability and demand. Nature's Sunshine Reports Second Quarter 2026 Results
• Negative Sentiment: The company lowered its full-year 2026 revenue outlook to $490 million–$500 million, below the analyst consensus of approximately $506.4 million. The reduced forecast likely reinforced investor concerns about slower growth. Nature's Sunshine misses Q2 2026 sales expectations

About Nature's Sunshine Products

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source